BioCryst Pharmaceuticals shares owned by EntryPoint Capital
Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by EntryPoint Capital
from 13F filings
Historical chart of EntryPoint Capital investment in BioCryst Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including BioCryst Pharmaceuticals held by EntryPoint Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in BioCryst Pharmaceuticals by EntryPoint Capital
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $409k | 54k | 7.60 |